Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model

Autor: Rasha Fadly Mady, Yasmine Amr Issa, Samar El Achy

Publikováno v: Memórias do Instituto Oswaldo Cruz, Volume: 114, Article number: e190062, Published: 05 AUG 2019
Memórias do Instituto Oswaldo Cruz., Vol 114
Memórias do Instituto Oswaldo Cruz

BACKGROUND Formation of schistosomal granulomata surrounding the ova can result in schistosomiasis-associated liver fibrosis (SSLF). The current standard of treatment is praziquantel (PZQ), which cannot effectively reverse SSLF. The role of the canna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5810532506a6e6ac3c2e92ca954d5245
https://doi.org/10.1590/0074-02760190062

Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model

Autor: Yasmine Amr Issa, Samar Nabil El Achy, Rasha Fadly Mady

Publikováno v: Memorias do Instituto Oswaldo Cruz, Vol 114

BACKGROUND Formation of schistosomal granulomata surrounding the ova can result in schistosomiasis-associated liver fibrosis (SSLF). The current standard of treatment is praziquantel (PZQ), which cannot effectively reverse SSLF. The role of the canna

Externí odkaz: https://doaj.org/article/57485edccfbf4468b49a90a29c5b9e26